Longevity Fund Fund II | 2011 VC Fund

Longevity Fund

Status

ACTIVE

Global HQ

Chicago, United States

Countries of investment

USA
Canada

Investment stages

Pre-Seed
Seed

Industries

Biotechnology
Health Tech
AI

About
The Longevity Fund focuses on breakthrough innovations in health and wellness that aim to extend human lifespan and improve overall health, supporting ventures with potential for significant impact in these areas.

Min check size: $100K
Max check size: $1M
Fund size: Unlock
NPS: Unlock

Investment Thesis

Invests in breakthrough innovations in health and wellness aimed at extending human lifespan.

Lead investor: Unlock
Co Invest: Unlock
Number of exits: Unlock
Preferred contact method: Unlock

Manager's Experience

Richard Glynne Ph.D. has experience in scientific leadership within the BioTech sector, particularly in the development of innovative therapeutics. Peptiboon Prasit Ph.D., with a strong background in biotech entrepreneurship, has cofounded and led several biotech ventures, focusing on drug discovery and development. Richard Van Doren Jr. specializes in financial management for biotech companies, bringing robust expertise in overseeing financial operations and strategy.